ChartMill assigns a Buy % Consensus number of 87% to ABEO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | Stifel | Maintains | Buy -> Buy |
| 2025-04-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-05 | Oppenheimer | Initiate | Outperform |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-29 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-03 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-30 | Stifel | Initiate | Buy |
| 2024-05-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-04-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-24 | Alliance Global Partners | Reiterate | Buy |
| 2022-11-14 | SVB Leerink | Maintains | Market Perform |
| 2022-11-08 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-08-11 | SVB Leerink | Maintains | Market Perform |
| 2021-11-30 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-11-29 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-19 | HC Wainwright & Co. | Maintains | Buy |
12 analysts have analysed ABEO and the average price target is 20.62 USD. This implies a price increase of 294.24% is expected in the next year compared to the current price of 5.23.
The consensus rating for ABEONA THERAPEUTICS INC (ABEO) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ABEONA THERAPEUTICS INC (ABEO) is 12.